Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment

The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.

Inclusion Criteria:

• aged 18 years or older,
• diagnosis of metastatic prostate cancer within 5 years,
• able to read and write,
• accepting and signing the informed consent

Exclusion Criteria:

• if patients are unable to complete the survey by themselves due to physical or psychological reasons,
• deemed ineligible by treating physicians if patients are unable to complete the survey by themselves due to physical or psychological reasons,
• deemed ineligible by treating physicians